Literature DB >> 9302198

Anti-endothelial cell antibody, thrombomodulin, and von Willebrand factor in idiopathic inflammatory myopathies.

K V Salojin1, A Bordron, E L Nassonov, V Z Shtutman, N G Guseva, A A Baranov, I N Targoff, P Youinou.   

Abstract

Sera from 19 patients with idiopathic inflammatory myopathy (IIM) were examined for the presence of anti-endothelial cell antibodies (AECA) by an immunoglobulin G-specific cellular enzyme-linked immunosorbent assay. The mean binding index of AECA was found to be 37.7% +/- 26.5% for the patients, compared with a mean of 7.2% +/- 2.7% for normal controls (P < 0.04). Levels of thrombomodulin, von Willebrand factor antigen, and serum creatine kinase were also shown to be augmented. Interestingly, positive correlations between AECA on the one hand and Raynaud's phenomenon and interstitial lung disease on the other were demonstrated. Given that the pathogenesis of IIM remains uncertain, these findings may be of importance.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9302198      PMCID: PMC170585          DOI: 10.1128/cdli.4.5.519-521.1997

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  23 in total

Review 1.  Polymyositis and dermatomyositis (second of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-20       Impact factor: 91.245

Review 2.  Autoantibodies in polymyositis.

Authors:  I N Targoff
Journal:  Rheum Dis Clin North Am       Date:  1992-05       Impact factor: 2.670

3.  Vascular damage and factor-VIII-related antigen in the rheumatic diseases.

Authors:  J J Belch; A A Zoma; I M Richards; K McLaughlin; C D Forbes; R D Sturrock
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

4.  Permanent cell line expressing human factor VIII-related antigen established by hybridization.

Authors:  C J Edgell; C C McDonald; J B Graham
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

5.  Human antibodies to vascular endothelium.

Authors:  K J Lindqvist; C K Osterland
Journal:  Clin Exp Immunol       Date:  1971-12       Impact factor: 4.330

6.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

7.  Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients.

Authors:  D Alarcón-Segovia; M H Cardiel
Journal:  J Rheumatol       Date:  1989-03       Impact factor: 4.666

8.  Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus.

Authors:  D B Cines; A P Lyss; M Reeber; M Bina; R J DeHoratius
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

9.  Microvascular deposition of complement membrane attack complex in dermatomyositis.

Authors:  J T Kissel; J R Mendell; K W Rammohan
Journal:  N Engl J Med       Date:  1986-02-06       Impact factor: 91.245

10.  Increased von Willebrand factor antigen in the plasma of patients with vasculitis.

Authors:  S R Nusinow; A B Federici; T S Zimmerman; J G Curd
Journal:  Arthritis Rheum       Date:  1984-12
View more
  1 in total

1.  Clinical significance of von Willebrand factor in patients with adult dermatomyositis.

Authors:  Toshiyuki Komiya; Nobuo Negoro; Kyoko Kondo; Katsuyuki Miura; Yoshio Hirota; Junichi Yoshikawa
Journal:  Clin Rheumatol       Date:  2004-11-23       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.